PubMed · 10125145
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
S Meister. 1993. Emerging risks: inappropriately prolonged mechanical ventilation.. https://pubmed.ncbi.nlm.nih.gov/10125145/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Price controls could have a substantial negative effect on pharmaceutical research and development. Extensive research is required before the development costs of a new drug or its benefits are known; most new drug development projects fail, sometimes after substantial financial and time costs. These conditions pose intractable practical problems for the operation of price controls, which cannot rest on objective, predictable standards such as the benefits or costs of individual drugs. In the absence of objective standards, pressure from health care providers and others would create powerful incentives for price regulators to decrease drug prices toward marginal costs of production and distribution, well below levels sufficient to reward innovative research. This downwardly biased price-setting mechanism would apply with particular force to the few successful projects that yield innovative drugs, whose prices would not be set by regulatory authorities until after research expenditures have been incurred and the new drugs are ready to enter the market. Manufacturers will expect price controls to reduce the potential payoffs from breakthrough drugs. This expectation would substantially reduce the incentives to pursue innovative research, as is evident in advanced economies in which price controls are now in force. Once established, price controls for pharmaceuticals, like those for medical services in the Medicare system, would also tend toward complexity and entrenchment of vested interests and could easily become permanent regardless of the harm they cause to patients.
Explore the source record for details and available documents.
Since the 1970s, market forces and cost containment have stimulated a range of economic changes for health care providers. There is increasing pressure for medical practices and other health care organizations to provide simultaneously excellent clinical, financial and satisfaction outcomes. To fulfill these expectations, two central aspects have been identified: customer focus and involvement of all members of a medical organization. Therefore, it is essential to understand the patient's perspective and, where necessary, increase quality of care from the customer's viewpoint. Generally, quality as defined by the customer and by the medical professionals differ substantially. In this article, we present a check-list to evaluate the essential aspects of a medical practice from a patient's view which, in turn, will help to determine which actions have to be taken. Some of the aspects covered by the checklist include satisfaction with care delivered, service performed, warmth of the employees, office's facilities, and physician's behavior.